Institutional investors purchased a net $8.5 million shares of CMXI during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 7.96% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRIGATE VENTURES LP Bought 8.5 Million shares of Cytomedix Inc